
Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness
Keywords: سرطان تخمدان; Ovarian cancer; Neoadjuvant therapy; Carboplatin and paclitaxel; Toxicity; Survival;